https://doi.org/10.4081/hmr.v2i15.610

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 114 adult patients

Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006
Published: June 16, 2009
Abstract Views: 337
PDF: 281
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

D Rund
support@pagepress.org
S Krichevsky
S Bar-Cohen
N Goldschmidt
M Kedmi
E Malik
A Gural
S Shafran-Tikva
S Ben-Neriah
D Ben-Yehuda
We studied the clinical characteristics of 114 patients with therapy-related leukemia or therapy related myelodysplastic syndrome (t-Leuk/MDS). The mean age of the patients was 48 years. The Hematological malignancies were the most common primary (53%), followed by breast and ovarian cancer (30% combined). The mean latency until the development of t-Leuk/MDS was 45.5 months. Median survival was 10 months. Cytogenetics was abnormal in 89% of the patients. FLT3 internal tandem duplications were found in six of 41 (14.6%) patients, of whom four had an abnormal karyotype

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Rund, D., Krichevsky, S., Bar-Cohen, S., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran-Tikva, S., Ben-Neriah, S., & Ben-Yehuda, D. (2009). Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 114 adult patients. Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.610
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).